NO951212L - Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus - Google Patents

Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus

Info

Publication number: NO951212L
Authority: NO; Norway
Prior art keywords: monoclonal antibodies; immunodeficiency virus; human; antibodies against; neutralizing monoclonal
Prior art date: 1992-09-30

Application number

NO951212A

Other languages

English (en)

Other versions

NO951212D0 (no

Inventor

Dennis R Burton

Carlos F Barbas

Richard A Lerner

Original Assignee

Scripps Research Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-30

Filing date

1995-03-29

Publication date

1995-05-29

1995-03-29 Application filed by Scripps Research Inst filed Critical Scripps Research Inst

1995-03-29 Publication of NO951212D0 publication Critical patent/NO951212D0/no

1995-05-29 Publication of NO951212L publication Critical patent/NO951212L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
- A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Animal Behavior & Ethology (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
AIDS & HIV (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Physics & Mathematics (AREA)
Optics & Photonics (AREA)
General Chemical & Material Sciences (AREA)
Radiology & Medical Imaging (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO951212A 1992-09-30 1995-03-29 Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus NO951212L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US95414892A	1992-09-30	1992-09-30
PCT/US1993/009328 WO1994007922A1 (en)	1992-09-30	1993-09-30	Human neutralizing monoclonal antibodies to human immunodeficiency virus

Publications (2)

Publication Number	Publication Date
NO951212D0 NO951212D0 (no)	1995-03-29
NO951212L true NO951212L (no)	1995-05-29

Family

ID=25495000

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO951212A NO951212L (no)	1992-09-30	1995-03-29	Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus

Country Status (10)

Country	Link
EP (1)	EP0675904B1 (no)
JP (1)	JPH08502260A (no)
AT (1)	ATE233814T1 (no)
AU (1)	AU681360B2 (no)
CA (1)	CA2145757A1 (no)
DE (1)	DE69332744T2 (no)
ES (1)	ES2194015T3 (no)
FI (1)	FI951488L (no)
NO (1)	NO951212L (no)
WO (1)	WO1994007922A1 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1231268T3 (da)	1994-01-31	2005-11-21	Univ Boston	Polyklonale antistofbiblioteker
US6780847B2 (en)	1995-04-27	2004-08-24	The United States Of America As Represented By The Department Of Health And Human Services	Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
US6987096B1 (en)	1995-04-27	2006-01-17	The United States Of America As Represented By The Department Of Health And Human Services	Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof
US7048935B2 (en)	1995-04-27	2006-05-23	The United States Of America As Represented By The Department Of Health And Human Services	Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US5843882A (en)	1995-04-27	1998-12-01	The United States Of America As Represented By The Department Of Health And Human Services	Antiviral proteins and peptides
US6428790B1 (en)	1995-04-27	2002-08-06	The United States Of America As Represented By The Secretary Department Of Health And Human Services	Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US6193982B1 (en)	1995-04-27	2001-02-27	The United States Of America As Represented By The Department Of Health & Human Services	Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120
US6255455B1 (en)	1996-10-11	2001-07-03	The Trustees Of The University Of Pennsylvania	Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
DE19809785C2 (de) *	1998-03-08	2000-02-10	Wolfgang Bergter	Radioimmunpharmakon zur Behandlung der HIV-1-Infektion
ATE249846T1 (de) *	1998-06-29	2003-10-15	Wolfgang Bergter	Antivirale und antiretrovirale radioimmunpharmaka auf der basis von alpha- und beta-strahlern
AU2487300A (en)	1998-12-31	2000-07-31	Chiron Corporation	Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2221600A (en)	1998-12-31	2000-07-31	Chiron Corporation	Improved expression of hiv polypeptides and production of virus-like particles
GB9908533D0 (en)	1999-04-14	1999-06-09	Novartis Ag	Organic compounds
US8288322B2 (en)	2000-04-17	2012-10-16	Dyax Corp.	Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
ES2400302T3 (es)	2000-04-17	2013-04-09	Dyax Corp.	Nuevos métodos para construir bibliotecas de paquetes génicos que presentan de forma colectiva los miembros de una familia diversa de péptidos, polipéptidos o proteínas
US20030119056A1 (en)	2000-12-18	2003-06-26	Ladner Robert Charles	Focused libraries of genetic packages
JP4307841B2 (ja)	2001-03-22	2009-08-05	アメリカ合衆国	グリコシル化抵抗性シアノビリン及び関連コンジュゲート、組成物、核酸、ベクター、宿主細胞、非グリコシル化シアノビリンの製造方法及び使用方法
JP5033303B2 (ja)	2001-07-05	2012-09-26	ノバルティスバクシンズアンドダイアグノスティックス，インコーポレーテッド	抗原性ｃ型ｈｉｖポリペプチドをコードするポリヌクレオチド、ポリペプチドおよびそれらの使用
US20030170614A1 (en)	2001-08-31	2003-09-11	Megede Jan Zur	Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
CA2463931A1 (en)	2001-10-16	2003-04-24	The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services	Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes
WO2003092630A2 (en)	2002-05-06	2003-11-13	The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries
US7566451B2 (en)	2002-05-06	2009-07-28	The United States Of America As Represented By The Department Of Health And Human Services	Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency
US20040067532A1 (en)	2002-08-12	2004-04-08	Genetastix Corporation	High throughput generation and affinity maturation of humanized antibody
US20070292390A1 (en) *	2004-10-29	2007-12-20	Dimitrov Dimiter S	Broadly Cross-Reactive Hiv-1 Neutralizing Human Monoclonal Antibodies
US8877688B2 (en)	2007-09-14	2014-11-04	Adimab, Llc	Rationally designed, synthetic antibody libraries and uses therefor
BRPI0816785A2 (pt)	2007-09-14	2017-05-02	Adimab Inc	bibliotecas de anticorpos sintéticos racionalmente desenhadas, e, usos para as mesmas
WO2009114815A1 (en)	2008-03-13	2009-09-17	Dyax Corp	Libraries of genetic packages comprising novel hc cdr3 designs
CA3049612C (en)	2008-04-24	2023-01-10	Dyax Corp.	Libraries of genetic packages comprising novel hc cdr1, cdr2, and cdr3 and novel lc cdr1, cdr2, and cdr3 designs
BR112013001175A2 (pt)	2010-07-16	2017-07-04	Adimab Llc	bibliotecas de anticorpos
EP2492279A1 (en)	2011-02-25	2012-08-29	Laboratorios Del. Dr. Esteve, S.A.	Rapid immunogen selection method using lentiviral display
EP2698377A1 (en)	2012-08-17	2014-02-19	Laboratorios Del. Dr. Esteve, S.A.	Enhanced rapid immunogen selection method for HIV gp120 variants
KR20230019227A (ko) *	2017-11-17	2023-02-07	그리폴스 다이어그노스틱 솔루션즈 인크.	신규한 포유동물 발현 인간 면역결핍 바이러스 외피 단백질 항원
IL294218A (en)	2019-12-27	2022-08-01	Chiome Bioscience Inc	Anti-cdcp1 antibody
CN116963779A (zh)	2020-09-02	2023-10-27	国立大学法人东京大学	癌症免疫微环境的调节物质及其预防、诊断或治疗
CN112521492B (zh) *	2020-12-18	2022-05-20	杭州贤至生物科技有限公司	乙肝表面抗原单克隆抗体的制备
WO2024024565A1 (ja)	2022-07-28	2024-02-01	国立大学法人東京大学	ニューロトリミンの機能阻害剤

1993
- 1993-09-30 EP EP93923749A patent/EP0675904B1/en not_active Expired - Lifetime
- 1993-09-30 JP JP6509318A patent/JPH08502260A/ja not_active Ceased
- 1993-09-30 ES ES93923749T patent/ES2194015T3/es not_active Expired - Lifetime
- 1993-09-30 CA CA002145757A patent/CA2145757A1/en not_active Abandoned
- 1993-09-30 WO PCT/US1993/009328 patent/WO1994007922A1/en active IP Right Grant
- 1993-09-30 DE DE69332744T patent/DE69332744T2/de not_active Expired - Fee Related
- 1993-09-30 AU AU53501/94A patent/AU681360B2/en not_active Ceased
- 1993-09-30 AT AT93923749T patent/ATE233814T1/de not_active IP Right Cessation
1995
- 1995-03-29 FI FI951488A patent/FI951488L/fi not_active Application Discontinuation
- 1995-03-29 NO NO951212A patent/NO951212L/no unknown

Also Published As

Publication number	Publication date
AU5350194A (en)	1994-04-26
EP0675904A1 (en)	1995-10-11
FI951488L (fi)	1995-05-23
NO951212D0 (no)	1995-03-29
WO1994007922A1 (en)	1994-04-14
EP0675904B1 (en)	2003-03-05
JPH08502260A (ja)	1996-03-12
CA2145757A1 (en)	1994-04-14
FI951488A0 (fi)	1995-03-29
EP0675904A4 (en)	1996-08-21
DE69332744D1 (de)	2003-04-10
DE69332744T2 (de)	2004-01-15
ATE233814T1 (de)	2003-03-15
ES2194015T3 (es)	2003-11-16
AU681360B2 (en)	1997-08-28

Publication	Publication Date	Title
NO951212L (no)	1995-05-29	Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus
NO970221L (no)	1997-03-18	Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus
DE69435126D1 (de)	2008-10-02	Synthetische humane neutralisierende monoklonale antikörper gegen hiv
NO950881D0 (no)	1995-03-07	Nöytraliserende monoklonale menneske-antistoffer mot andedretts-syncytial-virus
FI924819A0 (fi)	1992-10-23	Chimaera anti-icam-i-antikroppar foer maenniskobruk, foerfaranden foer deras framstaellning samt deras anvaendning
HUP9802212A2 (hu)	1999-01-28	Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
CO4480111A1 (es)	1997-07-09	Anticuerpos monoclonales de mono especificos para humanos b7. y/o b7.2, formas primatizadas de los mismos, composicio- nes farmaceuticas que los contienen, y uso de los mismos co- mo inmunosupresantes
ATE427488T1 (de)	2009-04-15	Monoklonaler antikírper fur die inhibierung von hiv-1-hullgykoprotein-vermittelte membranfusion
ES2067866T3 (es)	1995-04-01	Reactivos inmunologicos que reaccionan con un epitopo constante del virus inmunodeficiente humano del tipo i (vih-1)gp120 y metodos de utilizacion.
GR3029774T3 (en)	1999-06-30	Method of preparing a radioactive rhenium complex solution.
ES2114064T3 (es)	1998-05-16	Inmunoanalisis para la deteccion de colageno o fragmentos de colageno.
WO2004009785A3 (en)	2004-08-05	IgG Fc/HIV-gp120/C3d FUSION PROTEIN
MX9301858A (es)	1994-03-31	Anticuerpos monoclonales neutralizantes de hiv-humano recombinante para prevencion y tratamiento de infeccion hiv.
SE9201281D0 (sv)	1992-04-23	New human monoclonal antibodies, and a method for preparation thereof
WO1991010735A3 (fr)	1991-10-03	Recepteur humain de la tsh. sequence codant pour ce recepteur
AU4959193A (en)	1993-11-08	High affinity, strongly neutralizing monoclonal antibodies against the CD-4 binding site of GP120 of human immunodeficiency virus
ATE132502T1 (de)	1996-01-15	Peptide, die epitope auf r-ifn-beta repräsentieren, antikörper dagegen, und ihre anwendung
ATE309371T1 (de)	2005-11-15	Protein mit dnase-aktivität
ATE128733T1 (de)	1995-10-15	Monoklonale antikörper gegen hiv gp120.
DE69617255D1 (de)	2002-01-03	Durch hla-b44 moleküle präsentierte tumor-abstossungsantigene und ihre verwendung
DE59207362D1 (de)	1996-11-21	Monoklonale Antikörper gegen den Plasmin-Antiplasmin Komplex, Verfahren zu ihrer Herstellung sowie ihre Verwendung
ES2060162T3 (es)	1994-11-16	Utilizacion de los anticuerpos monoclonales anti-b2 microglobulina.
ES2051870T3 (es)	1994-07-01	Anticuerpo monoclonal capaz de suprimir la proliferacion de linfocitos t.
IT7919222A0 (it)	1979-01-11	Procedimento per produrre anticorpi umani.
FI850484L (fi)	1985-02-06	Diagnostiskt foerfarande, vid vilket man utnyttjar en ny monoklonal antikropp specifik mot maenniskans t-cellers antigen.